Top compounds associated with response to GDPGP1


Feature Type Standardized
Nominal ANOVA
mRNA lovastatin CTRPv2 pan-cancer AAC -0.18 1e-06
mRNA ML210 CTRPv2 pan-cancer AAC -0.12 0.0002
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0008
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA erastin CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.12 0.002
mRNA SN-38 GDSC1000 pan-cancer AAC -0.1 0.002
mRNA BMS-270394 CTRPv2 pan-cancer AAC -0.12 0.002
Download CSV